Metformin Slowed Frailty and Turned Back Epigenetic Clocks in Two-Year Trial
This study suggests metformin's anti-aging effects depend heavily on how you measure frailty.
Older adults with prediabetes took metformin or a placebo for two years. Those on metformin accumulated fewer health deficits over time, and two DNA-based age clocks in their blood ticked slower. The picture was mixed though: on the classic frailty checklist, metformin looked worse in year one, but only because the drug caused weight loss. It was well tolerated overall.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
Related Studies
All researchHeart-Healthy at 40 Meant Less Frailty and More Happiness at 79
Men who hit five basic health markers in their early 40s did not just live longer.
For Frail Older Adults, Gentle Cardio Beats Chasing a Perfect Dose
Looking across dozens of trials in frail and pre-frail people over 60, regular cardio improved frailty scores, mood, leg strength, quality…
